Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05555875 · ClinicalTrials.gov registry record · NA
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II
A NA study of Depression and Anxiety Disorders, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT05555875: Recruiting NA study of Depression and Anxiety Disorders, sponsored by Brigham and Women's Hospital.
NCT05555875 is a NA study of Depression and Anxiety Disorders that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 76 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05555875, a NA study of Depression and Anxiety Disorders, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.
Primary Outcome
disengagement from the digital mental health intervention is defined as the first week of \<1 minute of use after which there are no subsequent weeks with at least 1 minute of use
Conditions Studied
Interventions
- BEHAVIORAL IntelliCare Plus
Study Locations (1)
Massachusetts
- Jessica Morrow Lipschitz - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-06-07 |
| Est. Completion | 2025-07-20 |
| Phase | NA |
What NCT05555875 shows while recruiting
NCT05555875 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IntelliCare Plus is the first listed.
NCT05555875 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05555875 about?
NCT05555875 is a clinical study titled "Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II". This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.
What is the current status of trial NCT05555875?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-06-07. Estimated completion is 2025-07-20.
What conditions does trial NCT05555875 study?
This clinical trial studies the following conditions: Depression, Anxiety Disorders.
What interventions are being tested in trial NCT05555875?
The interventions under investigation include: IntelliCare Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT05555875?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05555875 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05555875's enrollment target sits among peer trials
76 384th of 679 higher than 294 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy